Dr Daniel D’Hotman
MBBS (Hons), BMedSc (Hons)
Daniel D’Hotman is an Australian Rhodes Scholar and medical doctor. He is currently completing a DPhil (PhD) on the ethics and politics of using AI for suicide prevention at the University of Oxford. Daniel is a co-author of Medicinal Use of Psilocybin: Reducing Restrictions on Treatment, a report commissioned by the Adam Smith Institute.
Daniel recently completed a Policy Fellowship at the Department of Prime Minister and Cabinet in Canberra, examining the potential to use digital technologies for mental illness. He has published a variety of academic papers, with one of these articles selected amongst the ‘Best in Philosophy’ collection for 2019 by Oxford University Press.
Dr Jesse Schnall
Jesse Schnall is a junior medical doctor from Melbourne and a co-author of Medicinal Use of Psilocybin: Reducing Restrictions on Treatment, a report commissioned by the Adam Smith Institute. He was a visiting philosophy student at the University of Oxford and an intern at the World Health Organization office at the United Nations. He believes that good healthcare should be accessible to everyone, and that good health policy should be based on evidence and compassion.
BSc, BMed (2021)